Why Is Abivax Stock Skyrocketing Tuesday?

Abivax SA (NASDAQ:ABVX) on Monday shared additional Phase 3 maintenance data for investigational ulcerative colitis therapy obefazimod. Following the announcement, the stock jumped nearly 36%. Abivax Reports Strong Phase 3 Maintenance Results For Obefazimod The data...